Agenda

The agenda is being continuously updated, please check back soon to see additional speakers.

Le Méridien Hotel
20 Sidney St, Cambridge, MA 02139

7:30–8:15 Breakfast

8:00–8:15 Welcome

Introduction to MedExecWomen

Helen Routh, Chair, MedExecWomen

8:15–8:45 Opening Keynote

Patient Keynote – Becoming the Story: The Power of Prehab 

Loriana Hernandez-Aldama, Patient Advocate and Founder, ArmorUp for Life

Loriana Hernandez-Aldama is an Emmy award-winning journalist, international speaker, 2x cancer survivor and author of Becoming the Story: The Power of PREhab. Bold, transparent and honest, Loriana has become a game-changer in the healthcare and wellness space. She will share what she discovered when she became the story, finding herself on the other side of healthcare after a 25 year on-air career. Her story of discovery and overcoming will leave you inspired and compelled to take action.  

8:45–9:30 Panel 1

What Are The Implications Of Multi-Billion Dollar Acquisitions In Medtech?

While billion dollar deals have become more common in Medtech, multi-billion dollar acquisitions are still notable, such as Baxter’s $10.5 B acquisition of Hill-Rom. Join MedExecWomen to hear our panelists discuss their roles in multi-billion dollar M&A, the strategies behind them, and the ripple effect across medtech when two large companies merge.

Moderated by: Maria Shepherd, President & CEO, Medi-Vantage

• Heather Knight, EVP, Group President - Medical Products & Therapies, Baxter International

• Jennifer Kozak, VP, Business Development, J&J Medtech

• Rebecca Schechter, SVP and General Manager, Dragon Ambient Experience, Nuance Healthcare

9:30–10:00 Break

10:00–10:45     Panel 2

Growth Expectations for the Life Sciences Market

For 2023 and beyond, how are the financial markets predicting and expecting companies to grow? Will M&A play a greater role in helping companies grow and how will deals be evaluated? How should strategics evaluate deals and how should smaller companies set themselves up for successful exits? Will top line revenue growth be sufficient or will companies need to think differently about margin expansion and shareholder return?

Moderated by: Jennifer Carter, Managing Director, Sandbox Healthcare & The Blue Venture Fund

• Meghna Eichelberger, Partner and Associate Director, Medical Technologies, BCG

• Kaila Krum, Partner, Braidwell

• Lauren Tengler, VP, Investor Relations, Boston Scientific

10:45–11:15 Executive Interview

Interview with Mary Beth Moynihan, SVP, Market Access and Chief Marketing Officer, Boston Scientific

Mary Beth Moynihan is Senior Vice President, Market Access and Chief Marketing Officer for Boston Scientific. In this role, she has responsibility for market access strategies that advance the availability of new medical technologies to patients based on economic evidence, as well as oversight of global communications and branding, digital marketing, marketing technology and customer experience. Mary Beth has been with Boston Scientific for over 25 years, starting as a marketing manager and director before assuming management-level positions of increasing responsibility. She is a founding board member of MedExecWomen and also serves on the board of Vapotherm.

11:15–12:30    Breakout Sessions

Grow Yourself: Critical Skills and Experiences

This session will provide insights on critical skills for executive women. This will involve an interactive approach to coalesce around general themes for executive women, identifying necessary competencies and working to develop action plans. Participants will explore their own key development needs and specific barriers to advancement.

SESSION TOPICS

• Coaching and Skill Building for Executive Women

  Moderated by: Martha Shadan, Medtech CEO and Board Member

  • Jennifer Buras, Senior Partner, Essex Partners

  • Lisa Considine, VP, Global Talent, Boston Scientific

• What Do Recruiters Say Are Important Skills for Female Executive Leadership?

  Moderated by: Stephanie Wimmer, Vice President, Health Economics, Policy and Reimbursement, Medical Surgical Portfolio, Medtronic

  • Leslie Loveless, CEO, Slone Partners

  • Nanaz Mohtashami, Managing Director & Global Practice Leader for MedTech, Russell Reynolds Associates

12:30–1:30      Lunch

1:30–2:15     Panel 3

Growth Dilemma: Business Resilience in a Time of Uncertainty

Medtech leaders face an uncertain landscape. From geopolitical tension and supply chain bottlenecks to soaring inflation, rising interest rates, and decelerating growth, businesses must navigate a range of complicated global headwinds. Despite these challenges, leaders have a powerful opportunity to build business resilience and competitive advantage.

Moderated by: Amy Hurwitz, Principal, BCG

• Catherine (Cathy) Burzik, CEO, CFB Interests, LLC

• Rachel Ellingson, SVP, Chief Strategy Officer, Zimmer Biomet

• Katie Fischer, Vice President - Strategic Customer Management, Johnson & Johnson MedTech

2:15–3:30      Panel 4

Inspiring the Future Generation of Female Leaders

Panel Discussion, followed by Breakout Sessions

As female executives we have a unique opportunity to inspire the future generations of female leaders both through our work and community involvement. Yet often females who wish to lead are not aware of their self-imposed constraints. This session will provide an opportunity to share experiences with women from across the breadth of MedTech, from large companies and small. It will be supported by an experienced executive coach and peer advisor who can help attendees identify areas of focus.

Moderated by: Helen Routh, Board President, MedExecWomen, Board Director & Advisor, formerly SVP
Philips

Facilitator: Michelle Barry, CEO/Executive Leadership Growth Coach, M Barry Consulting, LLC

• Angelique Johnson, Founder & CEO, MemSTIM, LLC

• Anita Khan, Head of HR, Ethicon US, Johnson & Johnson MedTech

3:30–4:00        Break

4:00–5:00        Panel 5

Growing New Markets: Lessons Learned and Words of Advice From MedTech Leaders

Times are changing and there are many opportunities for medtech to generate new value and growth beyond historic industry norms. Medtech companies willing to step out of the box can achieve this growth if they move beyond the traditional playbook. Join us in this MedExecWomen session where leaders share the new strategies and tactics.

Moderated by: Elena Pretto, Director, PwC

• Marta Gaia Zanchi, Founder & Managing Partner, Nina Capital

• Jean Olive, Chief Technology Officer, Best Buy Health

• Bhavana Nanjundaiah, GM, Imaging Fleet Solutions, GE Healthcare

• Colleen Riley, SVP & Chief Technology Officer, Embecta

5:00–5:30        Closing Keynote

Luba Greenwood, CEO, Kojin Therapeutics

Luba is a veteran biotech, pharmaceutical, tech, and life sciences investor and company builder. Luba serves as the Managing Partner of the Dana Farber Cancer Institute Venture Fund, Binney Street Capital (BSC), which she has built and launched. She is also the CEO of one of BSC’s portfolio companies Kojin Therapeutics, which is discovering and developing novel therapeutics in oncology, fibrosis, and immune modulation.

She is a professor at Harvard University in the School of Engineering and Applied Sciences. Luba has previously served in leadership roles at Google Life Sciences (Verily) and as Vice President of Global Business Development and Mergers & Acquisitions at Roche, where she also established and led the East Coast Innovation Hub. Luba has led $5B+ in deals and investments across multiple therapeutic areas and life sciences and tech sectors globally. She has served on multiple public, private, and non-profit boards and advised leading academic centers globally. Luba is also a former litigator and regulatory, policy, and IP expert, having started her career at Wilmer Cutler Pickering Hale and Dorr.

5:30–7:30        Closing Remarks, followed by Networking Wine Reception

Wine & Hors D’oeuvres

Covid Policy – Updated April 5, 2023

In light of both federal and state declarations noting May 11, 2023 as the end date for the Covid 19 public health emergency, on-site rapid testing will no longer be required or provided for conference attendees. For the health and safety of all, we strongly encourage all attendees to monitor for symptoms and test as needed prior to participating in conference activities. We remain mindful of individual preferences regarding mask-wearing and will have masks available for any attendees who would like them.